59676-225 : Olysio 150 mg/1 Oral Capsule
NDC: | 59676-225 |
Labeler: | Janssen Products Lp |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Oral Capsule |
Application #: | NDA205123 |
Rev. Date: |
Appearance:
Markings: | TMC435;150 |
Shapes: |
Capsule |
Colors: |
![]() |
Size (mm): | 22 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
![TMC435 150: (59676-225) Olysio 150 mg/1 Oral Capsule by Janssen Products Lp TMC435 150: (59676-225) Olysio 150 mg/1 Oral Capsule by Janssen Products Lp](/images/NDC/59676-225.jpg)
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 59676-225-07: 7 CAPSULE IN 1 BOTTLE (59676‑225‑07)
- 59676-225-28: 28 CAPSULE IN 1 BOTTLE (59676‑225‑28)
Active Ingredients:
- Simeprevir
Dosage Strength:
- 150 mg
Inactive Ingredients:
- Silicon Dioxide
- Croscarmellose Sodium
- Lactose Monohydrate
- Magnesium Stearate
- Sodium Lauryl Sulfate
- Gelatin
- Titanium Dioxide
- Ferrosoferric Oxide
- Shellac
Pharmaceutical Classes:
- Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]
- HCV NS3/4A Protease Inhibitors [MoA]
- Cytochrome P450 3A4 Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
- Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
- Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:![NDC 59676-225 QR Code](/images/NDC-QR/59676-225-QR.png)
< Prev: 59676-201Next: 59676-278 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.